masoprocol has been researched along with Palsy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ceballos, A; Floyd, RA; Gabbita, SP; Grammas, P; Hamdheydari, L; Hensley, K; Mai, T; Mhatre, M; Mou, S; Pye, QN; Stewart, C; West, M; West, S; Williamson, KS; Zemlan, F | 1 |
1 other study(ies) available for masoprocol and Palsy
Article | Year |
---|---|
The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice.
Topics: Administration, Oral; Age Factors; Animals; Behavior, Animal; Blotting, Northern; Blotting, Western; Body Mass Index; Cell Line; Curcumin; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Inhibitory Concentration 50; Lipoxygenase Inhibitors; Masoprocol; Mice; Mice, Transgenic; Microglia; Models, Neurological; Motor Activity; Nitric Oxide; Paralysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rotarod Performance Test; Spinal Cord; Statistics, Nonparametric; Superoxide Dismutase; Survival; tau Proteins; Tumor Necrosis Factor-alpha | 2004 |